FDA Peptide Reclassification 2026 Amanecia Health The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what GHK Cu Peptide Therapy Brea, CA Orange County GHK Cu (20 mg) 5 vials customsupplements GHK Cu Copper Peptide Research Compound Drexa Labs Nine Anticipated FDA Approvals for January 2026 Guideline Central